Company: CYTK
Filing Date: 2025-03-31
Form Type: PRE 14A
Source: 0001140361-25-011212
Chunk: 31

Company: CYTOKINETICS INC
Filing Date: 2025-03-31
Form: PRE 14A
Chunk 31
---
 for the 2025 Annual Meeting of Stockholders pursuant to the compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis, the related compensation tables and the narrative disclosure to those tables in the Proxy Statement.” The results of this advisory vote are not binding upon us. However, the Compensation Committee values the opinions expressed by stockholders in their vote, and will consider the outcome of the vote in deciding whether any actions are necessary to address concerns raised by the vote and when making future compensation decisions for named executive officers. The next scheduled “say on pay” vote will be at our 2026 annual meeting of stockholders.

| THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTEFORTHE ADVISORY PROPOSAL ON EXECUTIVE COMPENSATION. |

| 20 |     | Cytokinetics, Inc.|2025 Proxy Statement |

TABLE OF CONTENTS

Security Ownership of Certain Beneficial Owners and Management The following table sets forth certain information with respect to the beneficial ownership of Common Stock as of February 28, 2025 by:

| • | all those known by us at such time to be the beneficial owner of more than 5% of our voting securities; |

| • | each director and nominee for director at such time; |

| • | each of the named executive officers named in the Executive Summary Compensation Table; and |

| • | all executive officers, directors and nominees for director of the Company at such time as a group. |

The number and percentage of shares beneficially owned are based on the aggregate of 118,430,937 shares of Common Stock outstanding as of February 28, 2025, adjusted as required by the rules promulgated by the SEC.

| Name and Address of Beneficial Owner                                          |     |  Number of 
     Shares |     | Percent of   
 Common Stock 
 Outstanding  |
| 5% Stockholders(1):                                                           |     |            |     |              |
| Entities affiliated with BlackRock, Inc.(2)                                   
 50 Hudson Yards, New York, NY 10001                                           |     | 15,252,905 |     | 12.9%        |
| The Vanguard Group(3)                                                         
 100 Vanguard Boulevard, Malvern, PA 19355                                     |     | 11,915,821 |     | 10.1%        |
| Entities affiliated with Fidelity Investments(4)                              
 245 Summer Street, Boston, MA 02210